Lauren A. Moskowitz

Moskowitz’s representative matters include: 

Supreme Court

• Represented pro bono client Diana Montoya Alvarez at trial (as an associate) and appeal to the Second Circuit and the U.S. Supreme Court (argued as a first-year partner) in a precedential matter involving international law.  The trial and appellate courts all ruled in favor of Ms. Moskowitz’s client. 

Antitrust

• Served as lead trial counsel for Epic Games, creator of the hugely popular game Fortnite, in two high‑profile antitrust actions against Google and Apple alleging anticompetitive behavior in the distribution of mobile apps and the handling of in‑app payments. Ms. Moskowitz continues to represent Epic in connection with both matters. 
  • After a multi‑week trial in the case against Google, Ms. Moskowitz obtained a unanimous jury verdict in favor of Epic on all counts. In connection with this victory, she was recognized as The Am Law Litigation Daily’s “Litigator of the Week,” and the Cravath team received an Impact Case Award from Benchmark Litigation. In July 2025, Ms. Moskowitz secured a complete Ninth Circuit victory, which affirmed the jury verdict in Epic’s favor and upheld the permanent injunction against Google.
  • Following a three‑week bench trial in the Apple case, Ms. Moskowitz secured a permanent injunction against Apple’s anti‑steering policies. After another multi‑day trial, she obtained a ruling to enforce the permanent injunction, holding Apple in civil contempt and determining that Apple willfully violated the injunction.
• Representing Live Nation in antitrust litigation filed by the U.S. Department of Justice (DOJ), 39 states and the District of Columbia seeking to break up Live Nation/ Ticketmaster.
• Representing Epic Systems, a large provider of health information technology, in several matters, including:
  • An action filed by Particle Health in New York federal court asserting monopolization, among other claims, arising out of alleged conduct in an alleged market for “payer platforms.”
  • An action filed by CureIS Healthcare in California federal court asserting various claims, including monopolization, tortious interference, false advertising and unfair competition, related to electronic health record software.
• Represented Occidental Petroleum Corporation and certain of its subsidiaries, including Anadarko Petroleum Corporation, as defendants in antitrust litigation alleging that defendants exercised monopsony power over oil and gas production in Laramie County, Wyoming.  
• Represented Biosense Webster (a Johnson & Johnson subsidiary) in antitrust litigation brought by competitor Innovative Health alleging monopolization and restraint of trade in the nationwide market for the sale of high‑density mapping and ultrasound catheters. Ms. Moskowitz helped secure a summary judgment victory for Biosense.  
• Represented Word Collections, Inc., a performance rights organization for songwriters, music publishers, comedians and spoken word performers, in securing the dismissal of antitrust counterclaims brought by Pandora Media, LLC in California federal court.
• Represented Alcon Laboratories in connection with more than 50 class actions centralized in Florida federal court alleging that Alcon’s unilateral pricing policies for contact lenses violated Section 1 of the Sherman Act and state antitrust and consumer protection/unfair competition laws. The parties reached a favorable settlement on the eve of trial.  

General Commercial

• Represented Louis Dreyfus Company in its Fifth Circuit appeal in an action brought by the Port of Houston Authority relating to the lease agreement for a grain elevator, railroad system and surrounding infrastructure. Ms. Moskowitz argued the appeal on Louis Dreyfus’s behalf, and the parties subsequently reached a settlement to resolve the action.
• Represented the Boston Red Sox in litigation brought by daily fantasy sports contest participants relating to allegations involving electronic sign‑stealing. Ms. Moskowitz secured the dismissal of a consolidated purported class action filed by DraftKings participants, which was affirmed by the Second Circuit.
• Represented Goldman Sachs in securing the dismissal of breach of contract and fraud claims brought by a former client based on alleged breaches of obligations owed by Goldman Sachs in connection with the syndication of financing for a $3 billion acquisition. Ms. Moskowitz helped secure a unanimous appellate decision affirming the dismissal.
• Represented AngloGold Ashanti in litigation alleging breach of contract, fraudulent inducement and violations of federal and state securities statutes in connection with the company’s sale of a gold mine in Colorado. Ms. Moskowitz secured a summary judgment victory for AngloGold Ashanti resulting in dismissal of the case.
• Represented Credit Suisse in litigation brought by former Huntsman shareholders seeking hundreds of millions of dollars in alleged damages for alleged misrepresentations and common law fraud relating to the failed 2008 Huntsman/Hexion merger. The court granted summary judgment in favor of Ms. Moskowitz’s client and dismissed the case.
• Represented Renaissance Technologies in securing the dismissal of litigation alleging violations of federal and state RICO statutes in connection with Johnson & Johnson’s marketing of the antibiotic Levaquin. 
• Represented Medinol, a medical technology company, in an arbitration proceeding arising out of a contract dispute regarding the settlement of patent litigation.
• Represented Royal Dutch Shell in class action litigation in which it was accused of aiding and abetting human rights violations in Nigeria in violation of the Alien Tort Statute.  The district court dismissed plaintiffs’ claims and the Second Circuit Court of Appeals affirmed the district court’s decision, concluding that the statute does not create jurisdiction for suits against corporations.  The U.S. Supreme Court affirmed the Second Circuit decision.  Also represented Royal Dutch Shell in related litigation that settled.

Securities Litigation

• Represented Credit Suisse in residential mortgage‑backed securities litigation. Over the course of this representation, Ms. Moskowitz eliminated billions of dollars in claims against the company. She represented Credit Suisse in only the second RMBS investor suit ever to go to trial, which settled after five weeks of trial. She subsequently represented Credit Suisse in another lawsuit that settled on the first day of trial. Ms. Moskowitz also helped obtain a landmark ruling before New York’s highest court on the issue of statute of limitations under the Martin Act in a lawsuit brought by the New York Attorney General over $40 billion in RMBS sponsored by Credit Suisse.
• Represented CSX Corporation in a securities lawsuit arising from its proxy contest with two hedge funds. Ms. Moskowitz helped secure a judgment in favor of CSX after a bench trial.

Intellectual Property

• Representation of Abiomed, a global medical device company that develops groundbreaking cardiovascular products, in patent infringement litigation relating to guidance systems used in the company’s minimally invasive intravascular blood pumps.
• Represented Amgen as plaintiff in its retrial of a patent infringement case against Sanofi and Regeneron relating to Amgen’s patents covering a class of biologic drugs that treat high cholesterol, including Amgen’s drug Repatha®. Ms. Moskowitz was part of the trial team that won a jury verdict for Amgen.
• Represented INEOS Bio USA, LLC and INEOS Bio, Ltd. as plaintiffs in a trade secrets case concerning a revolutionary process for creating biofuels. The parties settled on terms favorable to INEOS.

Financial Restructuring & Reorganization

• Representing Silvergate Bank and its parent, Silvergate Capital Corporation, in connection with Silvergate Bank’s voluntary self-liquidation and a related chapter 11 filing for both entities.
• Represented Blackstone’s global credit business in an adversary proceeding and chapter 15 case brought by the bankruptcy estate of Norske Skogindustrier seeking the avoidance of certain transactions, helping to secure a favorable settlement shortly before a scheduled trial.
• Represented Fifth Season Investments, LLC, a Blue Owl life insurance investment portfolio company, in a dispute against GWG Holdings, Inc. and GWG Life, LLC (together “GWG”) concerning the payment of a break‑up fee owed in connection with GWG’s chapter 11 proceedings, securing a favorable settlement to resolve the action mid‑trial.
• Represented The Weinstein Company in its high-profile chapter 11 bankruptcy proceedings. After years of extensive negotiations, Ms. Moskowitz helped secure a global settlement and chapter 11 plan.
• Represented Stanley Black & Decker in a lawsuit against Sears related to the administrative consent program in its chapter 11 proceedings.
• Represented Dutch retailer HEMA B.V. in a U.S. chapter 15 proceeding related to its comprehensive debt restructuring and recapitalization transaction. As part of the transaction, HEMA pursued a creditors’ scheme of arrangement via the High Court of Justice of England and Wales and, led by Ms. Moskowitz, obtained chapter 15 recognition of the scheme by the U.S. Bankruptcy Court for the Southern District of New York.
• Represented Eurazeo North America, as manager of funds affiliated with Eurazeo SE, in its capacity as controlling shareholder of WorldStrides and lender under the $368 million DIP facility in the pre‑packaged chapter 11 proceedings of WorldStrides.
• Represented Credit Suisse, as administrative and collateral agent under the pre-petition Senior Secured Credit Agreement, in connection with litigation relating to the pre-packaged chapter 11 proceedings for Quorum Health Corporation. 
• Represented Credit Suisse as lender and administrative agent of the revolving credit facility provided to UCI International LLC and certain affiliates in connection with financing and litigation relating to the chapter 11 bankruptcy of UCI.